These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33095693)

  • 1. Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations.
    Durani U; Asante D; Heien HC; Thompson CA; Halfdanarson T; Sangaralingham L; Peethambaram P; Quevedo FJ; Villasboas JC; Go RS
    JCO Oncol Pract; 2021 Apr; 17(4):e490-e496. PubMed ID: 33095693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients With Diffuse Large B-cell Lymphoma (DLBCL) in Long-term Remission.
    Cheung MC; Mittmann N; Earle CC; Rahman F; Liu N; Singh S
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e27-e34. PubMed ID: 29102414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
    Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
    JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database.
    Abel GA; Vanderplas A; Rodriguez MA; Crosby AL; Czuczman MS; Niland JC; Gordon LI; Millenson M; Zelenetz AD; Friedberg JW; LaCasce AS
    Leuk Lymphoma; 2012 Jun; 53(6):1113-6. PubMed ID: 22098406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
    Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer.
    Lange SM; Choudry MM; Hunt TC; Ambrose JP; Haaland BA; Lowrance WT; Hanson HA; O'Neil BB
    Urol Oncol; 2023 Jan; 41(1):48.e19-48.e26. PubMed ID: 36307366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Surveillance Advanced Imaging and Serum Tumor Biomarker Testing Following Launch of the Choosing Wisely Initiative.
    Miles RC; Lee CI; Sun Q; Bansal A; Lyman GH; Specht JM; Fedorenko CR; Greenwood-Hickman MA; Ramsey SD; Lee JM
    J Natl Compr Canc Netw; 2019 Jul; 17(7):813-820. PubMed ID: 31319393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
    Huntington SF; Svoboda J; Doshi JA
    J Clin Oncol; 2015 May; 33(13):1467-74. PubMed ID: 25823735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choosing Wisely® in Hematology: Have We Made a Difference?
    Hilal T; Munoz J
    Curr Hematol Malig Rep; 2020 Aug; 15(4):241-247. PubMed ID: 32533390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M
    PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.
    Ruddy KJ; Sangaralingham LR; Van Houten H; Nowsheen S; Sandhu N; Moslehi J; Neuman H; Jemal A; Haddad TC; Blaes AH; Villarraga HR; Thompson C; Shah ND; Herrmann J
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005984. PubMed ID: 32106704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
    Sehdev A; Sherer EA; Hui SL; Wu J; Haggstrom DA
    Cancer; 2017 Jun; 123(12):2338-2351. PubMed ID: 28211937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Hematology 2020 Podcast Collection: FL and DLBCL.
    Fox CP; Osborne W
    Adv Ther; 2021 Jun; 38(Suppl 1):8-15. PubMed ID: 33687649
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
    Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
    Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation.
    Epperla N; Shah N; Hamadani M; Richardson K; Kapke JT; Patel A; Teegavarapu SP; Carrum G; Hari PN; Pingali SR; Karmali R; Fenske TS
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):672-678. PubMed ID: 27660080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
    Savani M; Gencturk M; Shanley R; Cayci Z; Wilke C; Warlick ED; He F; Janakiram M; Weisdorf DJ; Brunstein CG; Bachanova V
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):272-277. PubMed ID: 31669174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five hematologic tests and treatments to question.
    Hicks LK; Bering H; Carson KR; Haynes AE; Kleinerman J; Kukreti V; Ma A; Mueller BU; O'Brien SH; Panepinto JA; Pasquini MC; Rajasekhar A; Sarode R; Wood WA
    Blood; 2014 Dec; 124(24):3524-8. PubMed ID: 25472968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and study of knowledge and practice across different settings in Lebanon based on the recommendations of the American Society of Hematology Choosing Wisely campaign (ASK-PADS study).
    Saliba AN; Moukhadder H; Beydoun H; Harb A; Farhat R; Ghaddara HA; Taher AT
    Am J Hematol; 2018 Nov; 93(11):E350-E352. PubMed ID: 30058093
    [No Abstract]   [Full Text] [Related]  

  • 19. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question.
    O'Brien SH; Badawy SM; Rotz SJ; Shah MD; Makarski J; Bercovitz RS; Hogan MS; Luchtman-Jones L; Panepinto JA; Priola GM; Witmer CM; Wolfson JA; Yee M; Hicks LK
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28967. PubMed ID: 34047047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal medicine trainees' knowledge and confidence in using the American Society of Hematology Choosing Wisely guidelines in hemostasis, thrombosis, and non-malignant hematology.
    Marshall AL; Jenkins S; Oxentenko AS; Lee AI; Siegel MD; Katz JT; Vyas JM; Del Valle J; Mikhael JR
    PLoS One; 2018; 13(5):e0197414. PubMed ID: 29768480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.